Ozari Health sells compounded semaglutide for $86 a month. That is the lowest published price we have found for a GLP-1 anywhere, in all fifty states, with free shipping. The question worth asking of any number that low is what was removed to reach it — and here the answer is the assessment.
The Price Is the Story
Compounded semaglutide from $86 per month. Compounded tirzepatide from $125. For comparison, most of the compounded market sits between $150 and $300, and we have reviewed services asking $495 and $695 for the same two molecules.
Those are starting prices that will rise with dose, so treat them as the bottom of a range rather than a flat rate. Even allowing for that, Ozari is priced at the floor of this category — and it publishes the numbers openly rather than hiding them behind an intake.
It pairs that with a genuinely broad footprint: all 50 states, with licensed US physicians reviewing patient profiles. Telehealth prescribing is licensed state by state and a great many competitors serve a partial map or decline to say, so nationwide coverage is a real advantage rather than a marketing line. Delivery is free and expedited at three to five days, HSA and FSA cards are accepted, no insurance is needed, and the subscription can be cancelled at any time.
A Two-Minute Visit
The intake is advertised as a “2-Minute Visit”, with same-day doctor visits and a health questionnaire. There is no published BMI threshold, no eligibility criteria of any kind, and no mention of baseline laboratory testing anywhere on the pages we reached.
Two minutes is not an assessment. It is a form. For a medication with real contraindications — a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, gallbladder disease, and interactions that matter in pregnancy and with other drugs — the intake is the only thing standing between a customer and a prescription.
Baseline labs are not strictly required to prescribe a GLP-1, and plenty of reputable services skip them. But they do useful work: they can surface undiagnosed diabetes or thyroid dysfunction that changes what treatment is appropriate, establish kidney and liver function before starting, and give something objective to measure against later. Services like Hone Health and Marek Health build their whole model around them — and charge a great deal more.
That is the trade being made here, and it is worth naming plainly rather than pretending the low price is free. Ozari is not cheap because it found a clever supply chain; it is cheap in part because the clinical process is minimal. Whether that is acceptable depends entirely on how much you already know about your own health — which is exactly the thing a two-minute questionnaire cannot establish.
Buy Now, Pay Later on a Prescription
Ozari offers Affirm, Klarna and Afterpay at checkout. This is the first time we have found instalment financing attached to an ongoing GLP-1 prescription, and it deserves more attention than it will get.
Buy-now-pay-later products are built for discrete purchases — a sofa, a flight, a coat. You borrow once, repay over a few instalments, and it ends. A GLP-1 is the opposite shape: an indefinite recurring cost for a medication whose effects largely reverse when you stop taking it. Financing month one does nothing about month fourteen, and stacking instalment plans on a recurring subscription is how people end up with several overlapping obligations for a single ongoing treatment.
These products are also credit. Depending on the provider and plan, they can carry interest, late fees, and reporting that affects your credit file. None of that is disclosed on a product page — it lives in the financing provider’s terms, which is a second set of documents a patient now has to read alongside the medical ones.
The deeper issue is friction. Instalment financing exists to make a purchase feel smaller at the moment of decision. Applied to a prescription medication reached through a two-minute questionnaire, it removes the last thing that might have made someone pause. At $86 a month the medication is already among the most affordable in the category; a patient who needs financing to reach $86 is a patient for whom the twelve-month total — over $1,000 before any dose escalation — deserves a conversation, not a checkout button.
What It Gets Right
The compounding disclosure is good. Ozari states that compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality, and it labels both products as compounded rather than letting a customer assume otherwise. Several better-funded competitors we have reviewed will not say this plainly.
It also names both molecules, publishes both prices, and does not bury the cost behind a quiz. A dedicated clinical team and health concierge are described, along with personalised dosage adjustments and proactive monitoring — so the follow-up is presented as more substantial than the intake, which is at least the right way round.
And the fifty-state claim, if accurate, solves a real problem. Patients in states that most GLP-1 telehealth will not serve have few options, and a nationwide service at the lowest price in the market is a meaningful thing to exist.
Provider Facts
| Medications offered | Compounded semaglutide from $86/month and compounded tirzepatide from $125/month |
|---|---|
| Brand-name or compounded | Compounded, disclosed as not FDA-approved and not evaluated by the FDA for safety, effectiveness or quality |
| Consultation process | Fully online, advertised as a two-minute visit with same-day doctor review of a health questionnaire |
| Eligibility | Not published - no BMI threshold or eligibility criteria stated |
| Provider involvement | Licensed US physicians review profiles; a dedicated clinical team and health concierge are described for ongoing care |
| Lab requirements | Not published - no baseline testing described |
| Pharmacy fulfillment | Not named |
| Shipping frequency | Free expedited delivery, stated at three to five days |
| Support services | Dedicated clinical team, health concierge, personalised dosage adjustments and proactive monitoring |
| Membership fees | None stated - medication pricing is the cost |
| Medication fees | Semaglutide from $86/month, tirzepatide from $125/month; both are starting prices that rise with dose |
| Cancellation policy | Cancel anytime |
| Refund policy | A policy exists; terms not detailed on the pages we reached |
| Insurance | Not required and not billed |
| HSA/FSA | HSA and FSA accepted; Affirm, Klarna and Afterpay instalment plans offered |
| Availability | All 50 states |
Pros and Cons
Pros
- The lowest published GLP-1 prices in our review set — $86 and $125
- All 50 states, which few competitors match
- Names both molecules and publishes both prices openly
- Clear statement that compounded medication is not FDA-approved or evaluated
- Free expedited three-to-five-day delivery
- HSA and FSA accepted; no insurance needed
- Cancel anytime
Cons
- A two-minute intake is the thinnest clinical gate we have reviewed
- No BMI threshold or eligibility criteria published
- No baseline lab testing described anywhere
- Instalment financing offered on an indefinite recurring prescription
- Compounding pharmacy not named
- Refund terms not detailed
Who It May Be Best For
A strong fit if cost is the binding constraint, you have recent lab work and a clear picture of your own health from another clinician, and you know you tolerate this class of medication. At $86 a month it is the cheapest route we have found to a compounded GLP-1.
Also useful if you live somewhere most GLP-1 telehealth will not serve — nationwide coverage at this price is genuinely uncommon.
Get baseline labs before starting, even though Ozari does not ask for them. A basic metabolic panel, thyroid function and HbA1c through your own doctor costs far less than a month of medication and tells you things a two-minute form cannot.
Do not finance it. If $86 a month needs an instalment plan, the honest calculation is the annual total and what happens when the dose escalates — not four smaller payments on the first box.
Alternatives
Emerge Weight Loss costs more but bundles doctor review and overnight shipping. Hone Health builds in real lab testing at $65 a panel. Measured sells FDA-approved medication at published prices. Our cheapest GLP-1 programs page ranks the value end, and GLP-1 eligibility covers who should not take these drugs.
Limitations of This Review
Based on Ozari Health’s own published materials at ozarihealth.com, checked on 6 September 2026. The $86 and $125 figures are starting prices and will rise with dose; the price you are quoted after intake may differ. Anything marked not published means we could not find it on the pages we reached — eligibility screening and lab requirements may exist within the intake itself, which we did not complete, and our comments describe what is disclosed publicly rather than what happens clinically. The contraindications listed come from the approved labelling for this drug class, not from Ozari. Terms for Affirm, Klarna and Afterpay are set by those companies, not by Ozari. Nothing here is medical advice.
Frequently Asked Questions
Is $86 a month real?
It is the published starting price for compounded semaglutide, and the lowest we have found. It is a starting figure that rises with dose, so budget against the annual total at a maintenance dose rather than the first month.
Is the medication FDA-approved?
No. Both products are compounded, and Ozari states that compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.
Does a two-minute visit worry you?
It is the shortest intake we have reviewed, and no BMI criteria or baseline labs are published. GLP-1s have real contraindications, so we would want a fuller assessment — or would arrange labs independently before starting.
Should I use Klarna or Affirm to pay for it?
We would not. Instalment financing suits one-off purchases; a GLP-1 is an indefinite recurring cost, and stacking plans on a subscription is how overlapping obligations build up. These products can also carry interest, late fees and credit reporting.
Verdict
3.4 / 5 — from $86/month semaglutide, $125 tirzepatide
The lowest published prices in this category, nationwide, with honest labelling of what is being sold. The savings come out of the clinical process, and the instalment financing at checkout points the wrong way for a medication you may take for years.
The point worth carrying beyond this provider: when a price is far below the market, work out what was removed rather than assuming efficiency. Here it is visible and it is the assessment — which is recoverable, because you can get baseline labs yourself for less than a month of medication and bring the missing piece with you.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Ozari Health's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: September 6, 2026